Who owns Novo Nordisk (NVO)? Superinvestor holders
8 superinvestors of the 157 tracked here hold Novo Nordisk (NVO) in their latest 13F filing, with $2.1B between them. Tom Gayner gives it the most weight: 0.85% of the reported portfolio.
Andrew Spokes and Brandon Haley sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 8 of 157
- Biggest holder
- Dodge & Cox team, $771.6M
- Largest weight
- Tom Gayner, 0.85%of their portfolio
- Combined value
- $2.1B
- Bought last quarter
- 3
- Sold last quarter
- 6
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Tom GaynerMarkel Group | 0.85% | $108.8M | 2.87M | No change | 0 | Q3 2026 |
| 2 | Lee AinslieMaverick Capital | 0.72% | $79.3M | 1.65M | ▼ Reduced 20% | −426.21K | Q2 2026 |
| 3 | Sarah KettererCauseway Capital Management | 0.62% | $55.3M | 1.46M | ▼ Reduced 13% | −218.43K | Q3 2026 |
| 4 | Dodge & Cox teamDodge & Cox | 0.41% | $771.6M | 20.35M | ▼ Reduced 0.2% | −44.87K | Q3 2026 |
| 5 | John Overdeck and David Siegel (founders)Two Sigma Investments | 0.41% | $565.4M | 14.91M | ▲ Added more than 10× | +14.9M | Q3 2026 |
| 6 | Jim Simons (1938–2024)Renaissance Technologies | 0.24% | $177.3M | 4.68M | ▲ Added 54% | +1.64M | Q3 2026 |
| 7 | Charles Brandes (founder)Brandes Investment Partners | 0.22% | $31.5M | 831.31K | New | +831.31K | Q3 2026 |
| 8 | Ken FisherFisher Investments | 0.09% | $301.4M | 7.95M | ▼ Reduced 4.5% | −375.45K | Q3 2026 |
Sold out last quarter
- Andrew Spokeswas $125.6M · Q3 2026
- Brandon Haleywas $64.2M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 7 | 53.05M | $2B | 3 | 4 |
| Q2 2026 | 157 | 7 | 40.57M | $1.9B | 3 | 6 |
| Q1 2026 | 157 | 9 | 44.96M | $1.7B | 6 | 2 |
| Q4 2025 | 157 | 6 | 24.25M | $1.2B | 4 | 3 |
| Q3 2025 | 157 | 5 | 16.28M | $903.5M | 2 | 5 |
| Q2 2025 | 157 | 9 | 22.23M | $1.5B | 2 | 7 |
| Q1 2025 | 156 | 9 | 28.97M | $2B | 2 | 5 |
| Q4 2024 | 156 | 11 | 47.79M | $4.1B | 4 | 5 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Dodge & Cox team | 20.35M | 20.4M | 19.33M | — | — | — | — | — |
| John Overdeck and David Siegel (founders) | 14.91M | — | 6.29M | — | — | 2.22M | 3.15M | 1.84M |
| Ken Fisher | 7.95M | 8.32M | 9.02M | 9.78M | 10.32M | 11M | 11.87M | 12.64M |
| Jim Simons (1938–2024) | 4.68M | 3.03M | 3.4M | 3.18M | 2.88M | 4.94M | 6.82M | 8.31M |
| Tom Gayner | 2.87M | 2.87M | 2.87M | 2.87M | 2.37M | 2.26M | 2.15M | 2.15M |
| Sarah Ketterer | 1.46M | 1.68M | 1.17M | 993.85K | 695.98K | 353.88K | — | — |
| Charles Brandes (founder) | 831.31K | — | — | — | — | — | — | — |
| Andrew Spokes | — | 2.62M | 782K | — | — | — | — | — |
| Lee Ainslie | · | 1.65M | 2.08M | — | — | — | — | — |
| François Rochon | — | — | 12.4K | 12.4K | 12.4K | 12.4K | 12.4K | 12.4K |
| Ken Griffin | · | — | — | 7.41M | — | — | — | — |
| Chase Coleman | · | — | — | — | — | 1.27M | 1.27M | 1.27M |
| Polen Capital team | — | — | — | — | — | 178.67K | 1M | 6.41M |
| Rajiv Jain | — | — | — | — | — | 5.92K | 117.13K | 12.99M |
| David Shaw (founder) | · | — | — | — | — | — | 2.58M | 2.05M |
| Doug Silverman | — | — | — | — | — | — | — | 90K |
| Murray Stahl | — | — | — | — | — | — | — | 15.72K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own NVO?
In their latest 13F filings: Tom Gayner (0.85% of the portfolio, $108.8M), Lee Ainslie (0.72% of the portfolio, $79.3M), Sarah Ketterer (0.62% of the portfolio, $55.3M), Dodge & Cox team (0.41% of the portfolio, $771.6M), John Overdeck and David Siegel (founders) (0.41% of the portfolio, $565.4M), Jim Simons (1938–2024) (0.24% of the portfolio, $177.3M), Charles Brandes (founder) (0.22% of the portfolio, $31.5M), Ken Fisher (0.09% of the portfolio, $301.4M).
Who bought NVO last quarter?
John Overdeck and David Siegel (founders) (added 94,292%), Jim Simons (1938–2024) (added 54%), Charles Brandes (founder) (new position). “Last quarter” is each investor's latest reported quarter.
Who sold NVO last quarter?
Reduced: Lee Ainslie (20% fewer shares), Sarah Ketterer (13% fewer shares), Dodge & Cox team (0.2% fewer shares), Ken Fisher (4.5% fewer shares). Sold out entirely: Andrew Spokes (was $125.6M), Brandon Haley (was $64.2M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Novo Nordisk (NVO)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/NVO/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to NVO by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.